<i>In vitro</i> and <i>in vivo</i> identification of clinically approved drugs that modify <i> <scp>ACE</scp> 2 </i> expression

The COVID-19 pandemic caused by SARS-CoV-2 has is a global health challenge. Angiotensin-converting enzyme 2 (ACE2) is the host receptor for SARS-CoV-2 entry. Recent studies have suggested that patients with hypertension and diabetes treated with ACE inhibitors (ACEIs) or angiotensin receptor blocke...

全面介紹

Saved in:
書目詳細資料
Main Authors: Sanju Sinha, Kuoyuan Cheng, Alejandro A. Schäffer, Kenneth Aldape, Eyal Schiff, Eytan Ruppin
格式: Artigo
語言:英语
出版: 2020
在線閱讀:https://doi.org/10.15252/msb.20209628
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!